Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Adenosine and Glyburide

supplement:

Adenosine

Research Papers that Mention the Interaction

Glibenclamide also inhibited the carbachol and adenosine induced contractions.
Archives of pharmacal research  •  2009  |  View Paper
However, glibenclamide abrogated the protective effect of adenosine.
Acta cardiologica  •  2008  |  View Paper
Intracerebroventricular treatment of mice with …, 25 pg/site), glibenclamide (an ATP-sensitive K(+) channel inhibitor, 0.5 pg/site), charybdotoxin (a large- and intermediate-conductance calcium-activated K(+) channel …-conductance calcium-activated K(+) channel inhibitor, 10 pg/site) was able to potentiate the action of subeffective doses of adenosine (….)
Progress in Neuro-Psychopharmacology and Biological Psychiatry  •  2007  |  View Paper
When pretreated with glibenclamide (a nonselective ATP-sensitive potassium channel blocker), the inhibitory effects of adenosine and CPCA on blood pressure variability were significantly prevented.
Journal of cardiovascular pharmacology  •  2004  |  View Paper
Glibenclamide (0.3 μM) reduced significantly hypoxia-induced vasodilatation (differential change in CPP of −27±6%) as well as the dilator response to 10 μM adenosine and to the stable PGI2-analogue, iloprost.
Pflügers Archiv  •  2004  |  View Paper
Glibenclamide (10 nmol), a selective K(ATP) channels antagonist, suppressed the increase of ONH blood flow induced by 10 nmol adenosine significantly (P<0.001, ANOVA).
Experimental eye research  •  2004  |  View Paper
Further, vasodilator responses to neither adenosine nor ATP were sensitive to inhibition by the potassium channel blocker glibenclamide , in isolated mesenteric perfused bed.
Naunyn-Schmiedeberg's Archives of Pharmacology  •  2004  |  View Paper
Inhibition of the Na-K pump with ouabain or with low K + medium, as well as inhibition of the K ATP channels with glibenclamide , both diminished the adenosine induced vasodilation (P = 0.003, P = 0.01, and P = 0.003, respectively).
Current eye research  •  2002  |  View Paper
The A2A adenosine receptor‐mediated inhibitory responses to NECA were reduced by the KATP channel blocker, glibenclamide (3 μM) and abolished by charybdotoxin (100 nM).
British journal of pharmacology  •  2000  |  View Paper
N-LA, L-NAME and glibenclamide attenuated the effects of adenosine at doses of < 2.5 μM/ kg/min and pinacidil potentiated its effects.
Neonatology  •  2000  |  View Paper
Show More